{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:37:17Z","timestamp":1777307837834,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-024-01805-7","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T02:02:05Z","timestamp":1726884125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Levels of Natural Antibodies Before and After Immunoglobulin Replacement Treatment Affect the Clinical Phenotype in Common Variable Immunodeficiency"],"prefix":"10.1007","volume":"45","author":[{"given":"Ioannis","family":"Sarrigeorgiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimina","family":"Tsinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fani","family":"Kalala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Germenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthaios","family":"Speletas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Lymberi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,21]]},"reference":[{"issue":"1","key":"1805_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.18176\/jiaci.0388","volume":"30","author":"R Yazdani","year":"2020","unstructured":"Yazdani R, Habibi S, Sharifi L, Azizi G, Abolhassani H, Olbrich P, Aghamohammadi A. Common Variable Immunodeficiency: Epidemiology, Pathogenesis, Clinical Manifestations, Diagnosis, Classification, and Management. J Investig Allergol Clin Immunol. 2020;30(1):14\u201334. https:\/\/doi.org\/10.18176\/jiaci.0388.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"1805_CR2","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.3389\/fimmu.2018.02130","volume":"9","author":"R Ameratunga","year":"2018","unstructured":"Ameratunga R. Assessing Disease Severity in Common Variable Immunodeficiency Disorders (CVID) and CVID-Like Disorders. Front Immunol. 2018;9:2130. https:\/\/doi.org\/10.3389\/fimmu.2018.02130.","journal-title":"Front Immunol"},{"issue":"2","key":"1805_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/cei.12002","volume":"171","author":"V Gouilleux-Gruart","year":"2013","unstructured":"Gouilleux-Gruart V, Chapel H, Chevret S, Lucas M, Malphettes M, Fieschi C, Patel S, Boutboul D, Marson MN, G\u00e9rard L, Lee M, Watier H, Oksenhendler E, DEFI study group. Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor. Clin Exp Immunol. 2013;171(2):186\u201394. https:\/\/doi.org\/10.1111\/cei.12002.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"1805_CR4","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650\u20137. https:\/\/doi.org\/10.1182\/blood-2011-09-377945.","journal-title":"Blood"},{"issue":"1","key":"1805_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1684-1182(10)60002-3","volume":"43","author":"M Salehzadeh","year":"2010","unstructured":"Salehzadeh M, Aghamohammadi A, Rezaei N. Evaluation of immunoglobulin levels and infection rate in patients with common variable immunodeficiency after immunoglobulin replacement therapy. J Microbiol Immunol Infect. 2010;43(1):11\u20137. https:\/\/doi.org\/10.1016\/S1684-1182(10)60002-3.","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"1805_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0167-5699(05)80045-3","volume":"12","author":"S Avrameas","year":"1991","unstructured":"Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today. 1991 May;12(5):154\u20139. https:\/\/doi.org\/10.1016\/S0167-5699(05)80045-3.","journal-title":"Immunol Today"},{"key":"1805_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3389\/fimmu.2017.00872","volume":"8","author":"NE Holodick","year":"2017","unstructured":"Holodick NE, Rodr\u00edguez-Zhurbenko N, Hern\u00e1ndez AM. Defining Natural Antibodies. Front Immunol. 2017;8:872. https:\/\/doi.org\/10.3389\/fimmu.2017.00872.","journal-title":"Front Immunol"},{"issue":"10","key":"1805_CR8","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2174\/1871520615666150716104935","volume":"15","author":"A Jarossay","year":"2015","unstructured":"Jarossay A, Hadzhieva M, Kaveri SV, Lacroix-Desmazes S, Dimitrov JD. Natural and Induced Antibody Polyreactivity. Anticancer Agents Med Chem. 2015;15(10):1230\u201341. https:\/\/doi.org\/10.2174\/1871520615666150716104935.","journal-title":"Anticancer Agents Med Chem"},{"key":"1805_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/B978-0-12-820472-6.00197-3","volume-title":"Comprehensive Pharmacology","author":"P Lymberi","year":"2022","unstructured":"Lymberi P, Zannikou M, Hatzioannou A. Natural Autoantibodies in Health and Disease. In: Comprehensive Pharmacology, vol. 5. Elsevier; 2022. p. 342\u201368. https:\/\/doi.org\/10.1016\/B978-0-12-820472-6.00197-3."},{"issue":"2","key":"1805_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1615\/CritRevImmunol.2016018175","volume":"36","author":"TT Nguyen","year":"2016","unstructured":"Nguyen TT, Baumgarth N. Natural IgM and the Development of B Cell-Mediated Autoimmune Diseases. Crit Rev Immunol. 2016;36(2):163\u201377. https:\/\/doi.org\/10.1615\/CritRevImmunol.2016018175.","journal-title":"Crit Rev Immunol"},{"key":"1805_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/82_2017_37","volume":"408","author":"PI Lobo","year":"2017","unstructured":"Lobo PI. Role of Natural IgM Autoantibodies (IgM-NAA) and IgM Anti-Leukocyte Antibodies (IgM-ALA) in Regulating Inflammation. Curr Top Microbiol Immunol. 2017;408:89\u2013117. https:\/\/doi.org\/10.1007\/82_2017_37.","journal-title":"Curr Top Microbiol Immunol"},{"key":"1805_CR12","doi-asserted-by":"publisher","first-page":"109070","DOI":"10.1016\/j.clim.2022.109070","volume":"241","author":"JM Bernth Jensen","year":"2022","unstructured":"Bernth Jensen JM, Hansen AT, S\u00f6derstr\u00f6m A, J\u00f8rgensen CS, Larsen CS, Skov S\u00f8rensen UB, Thiel S, Petersen MS. A low level of naturally occurring antibodies associates with functional antibody deficiency. Clin Immunol. 2022 Aug;241:109070. https:\/\/doi.org\/10.1016\/j.clim.2022.109070.","journal-title":"Clin Immunol"},{"issue":"3","key":"1805_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1365-2249.2012.04656.x","volume":"170","author":"O Suchanek","year":"2012","unstructured":"Suchanek O, Sadler R, Bateman EA, Patel SY, Ferry BL. Immunophenotyping of putative human B1 B cells in healthy controls and common variable immunodeficiency (CVID) patients. Clin Exp Immunol. 2012 Dec;170(3):333\u201341. https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04656.x.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1805_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1182\/blood.V62.2.264.264","volume":"62","author":"G Dighiero","year":"1983","unstructured":"Dighiero G, Guilbert B, Fermand JP, Lymberi P, Danon F, Avrameas S. Thirty-six human monoclonal immunoglobulins with antibody activity against cytoskeleton proteins, thyroglobulin, and native DNA: immunologic studies and clinical correlations. Blood. 1983;62(2):264\u201370. https:\/\/doi.org\/10.1182\/blood.V62.2.264.264.","journal-title":"Blood"},{"issue":"4","key":"1805_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/s0896-8411(03)00036-2","volume":"20","author":"A Zamanou","year":"2003","unstructured":"Zamanou A, Samiotaki M, Panayotou G, Margaritis L, Lymberi P. Fine specificity and subclasses of IgG anti-actin autoantibodies differ in health and disease. J Autoimmun. 2003;20(4):333\u201344. https:\/\/doi.org\/10.1016\/s0896-8411(03)00036-2.","journal-title":"J Autoimmun"},{"key":"1805_CR16","doi-asserted-by":"publisher","first-page":"808008","DOI":"10.3389\/fimmu.2021.808008","volume":"12","author":"OP Rekvig","year":"2022","unstructured":"Rekvig OP. The Anti-DNA Antibodies: Their Specificities for Unique DNA Structures and Their Unresolved Clinical Impact-A System Criticism and a Hypothesis. Front Immunol. 2022;12:808008. https:\/\/doi.org\/10.3389\/fimmu.2021.808008.","journal-title":"Front Immunol"},{"issue":"5","key":"1805_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1055\/s-2007-960498","volume":"115","author":"A Alver","year":"2007","unstructured":"Alver A, Mente\u015fe A, Karahan SC, Erem C, Keha EE, Arikan MK, Emina\u011fao\u011flu MS, Deger O. Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease. Exp Clin Endocrinol Diabetes. 2007;115(5):287\u201391. https:\/\/doi.org\/10.1055\/s-2007-960498.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1805_CR18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1100\/tsw.2011.107","volume":"11","author":"RJ Brezski","year":"2011","unstructured":"Brezski RJ, Knight DM, Jordan RE. The origins, specificity, and potential biological relevance of human anti-IgG hinge autoantibodies. ScientificWorldJournal. 2011;11:1153\u201367. https:\/\/doi.org\/10.1100\/tsw.2011.107.","journal-title":"ScientificWorldJournal"},{"issue":"Suppl 1","key":"1805_CR19","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1093\/infdis\/jiu512","volume":"212","author":"S Gunti","year":"2015","unstructured":"Gunti S, Notkins AL. Polyreactive Antibodies: Function and Quantification. J Infect Dis. 2015;212(Suppl 1):S42\u20136. https:\/\/doi.org\/10.1093\/infdis\/jiu512.","journal-title":"J Infect Dis"},{"key":"1805_CR20","unstructured":"ESID - European Society for Immunodeficiencies. https:\/\/esid.org\/Working-Parties\/Registry-Working-Party\/Diagnosis-criteria (accessed 2024-02-15)"},{"key":"1805_CR21","doi-asserted-by":"publisher","first-page":"765","DOI":"10.4049\/jimmunol.134.2.765","volume":"134","author":"G Dighiero","year":"1985","unstructured":"Dighiero G, Lymberi P, Holmberg D, Lundquist I, Coutinho A, Avrameas S. High frequency of natural autoantibodies in normal newborn mice. J Immunol. 1985;134:765\u201371.","journal-title":"J Immunol"},{"issue":"10","key":"1805_CR22","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1038\/cti.2015.18","volume":"4","author":"AD Sali","year":"2015","unstructured":"Sali AD, Karakasiliotis I, Evangelidou M, Avrameas S, Lymberi P. Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin. Clin Transl Immunology. 2015;4(10):e42. https:\/\/doi.org\/10.1038\/cti.2015.18.","journal-title":"Clin Transl Immunology"},{"issue":"1","key":"1805_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, Vlkova M, Hernandez M, Detkova D, Bos PR, Poerksen G, von Bernuth H, Baumann U, Goldacker S, Gutenberger S, Schlesier M, Bergeron-van der Cruyssen F, Le Garff M, Debr\u00e9 P, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77\u201385. https:\/\/doi.org\/10.1182\/blood-2007-06-091744.","journal-title":"Blood"},{"issue":"1","key":"1805_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, Espinosa-Rosales FJ, Hammarstr\u00f6m L, Nonoyama S, Quinti I, Routes JM, Tang ML, Warnatz K. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract. 2016;4(1):38\u201359. https:\/\/doi.org\/10.1016\/j.jaip.2015.07.025.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"1805_CR25","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood.v99.5.1544","volume":"99","author":"K Warnatz","year":"2002","unstructured":"Warnatz K, Denz A, Dr\u00e4ger R, Braun M, Groth C, Wolff-Vorbeck G, Eibel H, Schlesier M, Peter HH. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002;99(5):1544\u201351. https:\/\/doi.org\/10.1182\/blood.v99.5.1544.","journal-title":"Blood"},{"issue":"302","key":"1805_CR26","doi-asserted-by":"publisher","first-page":"302ra135","DOI":"10.1126\/scitranslmed.aab1216","volume":"7","author":"KM Roskin","year":"2015","unstructured":"Roskin KM, Simchoni N, Liu Y, Lee JY, Seo K, Hoh RA, Pham T, Park JH, Furman D, Dekker CL, Davis MM, James JA, Nadeau KC, Cunningham-Rundles C, Boyd SD. IgH sequences in common variable immune deficiency reveal altered B cell development and selection. Sci Transl Med. 2015;7(302):302ra135. https:\/\/doi.org\/10.1126\/scitranslmed.aab1216.","journal-title":"Sci Transl Med"},{"issue":"22","key":"1805_CR27","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1182\/blood.2019001705","volume":"134","author":"P Jandus","year":"2019","unstructured":"Jandus P, Boligan KF, Smith DF, de Graauw E, Grimbacher B, Jandus C, Abdelhafez MM, Despont A, Bovin N, Simon D, Rieben R, Simon HU, Cummings RD, von Gunten S. The architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies. Blood. 2019;134(22):1941\u201350. https:\/\/doi.org\/10.1182\/blood.2019001705.","journal-title":"Blood"},{"issue":"1","key":"1805_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12969-023-00823-w","volume":"21","author":"E Tsitsami","year":"2023","unstructured":"Tsitsami E, Sarrigeorgiou I, Tsinti M, Rouka EC, Zarogiannis SG, Lymberi P. Natural autoimmunity in oligoarticular juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2023;21(1):44. https:\/\/doi.org\/10.1186\/s12969-023-00823-w.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"1805_CR29","first-page":"271","volume":"48","author":"PI Terness","year":"2002","unstructured":"Terness PI, Navolan D, Dufter C, Welschof M, Opelz G. Immunosuppressive anti-immunoglobulin autoantibodies: specificity, gene structure and function in health and disease. Cell Mol Biol (Noisy-le-grand). 2002;48(3):271\u20138.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"1805_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fimmu.2016.00127","volume":"7","author":"TL Rothstein","year":"2016","unstructured":"Rothstein TL. Natural Antibodies as Rheostats for Susceptibility to Chronic Diseases in the Aged. Front Immunol. 2016;7:127. https:\/\/doi.org\/10.3389\/fimmu.2016.00127.","journal-title":"Front Immunol"},{"issue":"1","key":"1805_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.chom.2007.01.002","volume":"1","author":"ZH Zhou","year":"2007","unstructured":"Zhou ZH, Zhang Y, Hu YF, Wahl LM, Cisar JO, Notkins AL. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe. 2007;1(1):51\u201361. https:\/\/doi.org\/10.1016\/j.chom.2007.01.002.","journal-title":"Cell Host Microbe"},{"issue":"13","key":"1805_CR32","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1084\/jem.20100034","volume":"207","author":"RR Rapaka","year":"2010","unstructured":"Rapaka RR, Ricks DM, Alcorn JF, Chen K, Khader SA, Zheng M, Plevy S, Bengt\u00e9n E, Kolls JK. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J Exp Med. 2010;207(13):2907\u201319. https:\/\/doi.org\/10.1084\/jem.20100034.","journal-title":"J Exp Med"},{"issue":"2","key":"1805_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jaci.2004.10.048","volume":"115","author":"R Carsetti","year":"2005","unstructured":"Carsetti R, Rosado MM, Donnanno S, Guazzi V, Soresina A, Meini A, Plebani A, Aiuti F, Quinti I. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol. 2005;115(2):412\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2004.10.048.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1805_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4049\/immunohorizons.2100014","volume":"5","author":"MA Mella","year":"2021","unstructured":"Mella MA, Lavrinienko A, Akhi R, Hindstr\u00f6m R, Nissinen AE, Wang C, Kullaa A, Salo T, Auvinen J, Koskim\u00e4ki JJ, H\u00f6rkk\u00f6 S. Compensatory IgM to the Rescue: Patients with Selective IgA Deficiency Have Increased Natural IgM Antibodies to MAA-LDL and No Changes in Oral Microbiota. Immunohorizons. 2021;5(4):170\u201381. https:\/\/doi.org\/10.4049\/immunohorizons.2100014.","journal-title":"Immunohorizons"},{"issue":"7","key":"1805_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.15761\/CCRR.1000149","volume":"1","author":"SN Shah","year":"2015","unstructured":"Shah SN, Todoric K, Tarrant TK. Improved outcomes on subcutaneous IgG in patients with humoral immunodeficiency and co-morbid bowel disease. Clin Case Rep Rev. 2015;1(7):151\u20132. https:\/\/doi.org\/10.15761\/CCRR.1000149.","journal-title":"Clin Case Rep Rev"},{"key":"1805_CR36","doi-asserted-by":"publisher","unstructured":"Ding Y, Fern Ndez-Montero A, Mani A, Casadei E, Shibasaki Y, Takizawa F, Miyazawa R, Salinas I, Sunyer JO. Secretory IgM (sIgM) is an ancient master regulator of microbiota homeostasis and metabolism. bioRxiv. 2023; https:\/\/doi.org\/10.1101\/2023.02.26.530119.","DOI":"10.1101\/2023.02.26.530119"},{"key":"1805_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fimmu.2012.00066","volume":"3","author":"C Gr\u00f6nwall","year":"2012","unstructured":"Gr\u00f6nwall C, Vas J, Silverman GJ. Protective Roles of Natural IgM Antibodies. Front Immunol. 2012;3:66. https:\/\/doi.org\/10.3389\/fimmu.2012.00066.","journal-title":"Front Immunol"},{"issue":"11","key":"1805_CR38","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.autrev.2012.02.006","volume":"11","author":"SV Kaveri","year":"2012","unstructured":"Kaveri SV. Intravenous immunoglobulin: exploiting the potential of natural antibodies. Autoimmun Rev. 2012;11(11):792\u20134. https:\/\/doi.org\/10.1016\/j.autrev.2012.02.006.","journal-title":"Autoimmun Rev"},{"key":"1805_CR39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3389\/fimmu.2014.00690","volume":"5","author":"A Matucci","year":"2015","unstructured":"Matucci A, Maggi E, Vultaggio A. Mechanisms of action of Ig preparations: immunomodulatory and anti-inflammatory effects. Front Immunol. 2015;5:690. https:\/\/doi.org\/10.3389\/fimmu.2014.00690.","journal-title":"Front Immunol"},{"issue":"3","key":"1805_CR40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/cei.12008","volume":"171","author":"K Kraljevic","year":"2013","unstructured":"Kraljevic K, Wong S, Fulcher DA. Circulating phenotypic B-1 cells are decreased in common variable immunodeficiency and correlate with immunoglobulin M levels. Clin Exp Immunol. 2013;171(3):278\u201382. https:\/\/doi.org\/10.1111\/cei.12008.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1805_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/ajts.AJTS_15_17","volume":"14","author":"M Mosaed","year":"2020","unstructured":"Mosaed M, Pourfathollah AA, Moghadam M, Jazayeri MH, Safdarian AR. Evaluation of serum natural autoantibodies reaction in different hematological disorders with prospective view to their probable utilization in predictive medicine. Asian J Transfus Sci. 2020;14(2):167\u201371. https:\/\/doi.org\/10.4103\/ajts.AJTS_15_17.","journal-title":"Asian J Transfus Sci"},{"key":"1805_CR42","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3389\/fimmu.2018.01925","volume":"9","author":"JD Langereis","year":"2018","unstructured":"Langereis JD, van der Flier M, de Jonge MI. Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections. Front Immunol. 2018;9:1925. https:\/\/doi.org\/10.3389\/fimmu.2018.01925.","journal-title":"Front Immunol"},{"issue":"3","key":"1805_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00005-016-0422-x","volume":"65","author":"PJ Sp\u00e4th","year":"2017","unstructured":"Sp\u00e4th PJ, Schneider C, von Gunten S. Clinical Use and Therapeutic Potential of IVIG\/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations. Arch Immunol Ther Exp (Warsz). 2017;65(3):215\u201331. https:\/\/doi.org\/10.1007\/s00005-016-0422-x.","journal-title":"Arch Immunol Ther Exp (Warsz)"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01805-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01805-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01805-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:47:22Z","timestamp":1777304842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01805-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,21]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1805"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01805-7","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,21]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent Statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13"}}